DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Voclosporin

Voclosporin

  • Application Withdrawal Assessment Report for Luveniq

    Application Withdrawal Assessment Report for Luveniq

  • Benlysta® (Belimumab)

    Benlysta® (Belimumab)

  • Prior Authorization Lupkynis™ (Voclosporin Capsules)

    Prior Authorization Lupkynis™ (Voclosporin Capsules)

  • Lupkynis (Voclosporin Capsules) Annual Review Date: 02/18/2021

    Lupkynis (Voclosporin Capsules) Annual Review Date: 02/18/2021

  • Changes to the Drug Formularies

    Changes to the Drug Formularies

  • Immunfarmakológia Immunfarmakológia

    Immunfarmakológia Immunfarmakológia

  • Future Therapies for Chronic Noninfectious Uveitis New Drugs and Innovative Drug Delivery Systems Will Pave the Way for Future Treatments in Uveitis

    Future Therapies for Chronic Noninfectious Uveitis New Drugs and Innovative Drug Delivery Systems Will Pave the Way for Future Treatments in Uveitis

  • Health Plan Insights

    Health Plan Insights

  • Rxoutlook® 4Th Quarter 2020

    Rxoutlook® 4Th Quarter 2020

  • Drugs in Development for Prophylaxis of Rejection in Kidney-Transplant Recipients

    Drugs in Development for Prophylaxis of Rejection in Kidney-Transplant Recipients

  • Voclosporin (Lupkynis™) EOCCO POLICY

    Voclosporin (Lupkynis™) EOCCO POLICY

  • Lupus Prior Authorization with Quantity Limit Program Summary

    Lupus Prior Authorization with Quantity Limit Program Summary

  • Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities

    Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities

  • MM&M Takes a Detailed Look at Key Products in the Pipeline

    MM&M Takes a Detailed Look at Key Products in the Pipeline

  • Novel Immunosuppressive Agents in Kidney Transplantation

    Novel Immunosuppressive Agents in Kidney Transplantation

  • OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS

    OCTOBER 2019 Mrx Pipeline a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS

  • Serve You Rx Prior Authorization Information and Drug List

    Serve You Rx Prior Authorization Information and Drug List

  • Long-Term Outcome of a Randomised Controlled Trial Comparing

    Long-Term Outcome of a Randomised Controlled Trial Comparing

Top View
  • Recent Topics on the Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities
  • Oxford Policy Update Bulletin: March 2021
  • Belimumab and Voclosporin for Lupus Nephritis: Effectiveness and Value
  • Self-Administered Specialty Drug List
  • FEP 5 Tier Rx Drug Formulary (607) Standard Option
  • Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
  • NYS Medicaid Fee-For-Service Preferred Drug List PREFERRED DRUG LIST – TABLE of CONTENTS I
  • Evaluation of Experimental Autoimmune Uveitis in Mice Treated with FTY720
  • ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
  • Pharmaabkommen A1 E
  • Annual Report 2013
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • Guideline for Vaccinations Project
  • Voclosporin) Capsules, for Oral Use • Patients with Mild and Moderate Hepatic Impairment: the Initial U.S
  • Differential Effects of Voclosporin and Tacrolimus on Insulin Secretion from Human Islets
  • New Oral Small Molecules for Lupus and Related Diseases
  • P&T Summary 2Q2021
  • Novel Psoriasis Therapies and Patient Outcomes, Part 3: Systemic Medications


© 2024 Docslib.org    Feedback